ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,372
Screening encounters
2,596
Diagnostic referrals
501
Outstanding pathways
206

Screening pathway

  1. Screening2,596Encounters
  2. Positive finding874Documented findings
  3. Referral501Diagnostic referrals
  4. Follow-up569Diagnostic visits
  5. Outcome295Resolved pathways

Stage totals use different units. Pending pathways: 206. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 4792 · EXP-4792Synthetic · Site B

Full participant history through 2026-02-25, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-04-06
  4. · Diagnostic referral · EXP-4792-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Attended
  8. · Diagnosis · Colposcopy · Biopsy collected
  9. · Diagnosis · Histopathology · No high-grade lesion identified
  10. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-12-05
  11. · Follow-up disposition · Resolved · EXP-4792-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

2372 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2960 · Expanded synthetic participant 2960Site B — Peri-Urban Access Programme
EXP-2961 · Expanded synthetic participant 2961Site E — Resource-Constrained Navigation Programme
EXP-2962 · Expanded synthetic participant 2962Site E — Resource-Constrained Navigation Programme
EXP-2969 · Expanded synthetic participant 2969Site D — Community Engagement Programme
EXP-2972 · Expanded synthetic participant 2972Site A — Urban Referral Hub
EXP-2973 · Expanded synthetic participant 2973Site B — Peri-Urban Access Programme
EXP-2976 · Expanded synthetic participant 2976Site E — Resource-Constrained Navigation Programme
EXP-2980 · Expanded synthetic participant 2980Site E — Resource-Constrained Navigation Programme
EXP-2987 · Expanded synthetic participant 2987Site E — Resource-Constrained Navigation Programme
EXP-2988 · Expanded synthetic participant 2988Site C — Rural Outreach Programme
EXP-2989 · Expanded synthetic participant 2989Site A — Urban Referral Hub
EXP-2990 · Expanded synthetic participant 2990Site C — Rural Outreach Programme
EXP-2992 · Expanded synthetic participant 2992Site B — Peri-Urban Access Programme
EXP-2993 · Expanded synthetic participant 2993Site A — Urban Referral Hub
EXP-2997 · Expanded synthetic participant 2997Site E — Resource-Constrained Navigation Programme
EXP-2999 · Expanded synthetic participant 2999Site B — Peri-Urban Access Programme
EXP-3001 · Expanded synthetic participant 3001Site A — Urban Referral Hub
EXP-3003 · Expanded synthetic participant 3003Site C — Rural Outreach Programme
EXP-3005 · Expanded synthetic participant 3005Site D — Community Engagement Programme
EXP-3006 · Expanded synthetic participant 3006Site C — Rural Outreach Programme
EXP-3008 · Expanded synthetic participant 3008Site C — Rural Outreach Programme
EXP-3011 · Expanded synthetic participant 3011Site E — Resource-Constrained Navigation Programme
EXP-3015 · Expanded synthetic participant 3015Site C — Rural Outreach Programme
EXP-3018 · Expanded synthetic participant 3018Site B — Peri-Urban Access Programme
EXP-3021 · Expanded synthetic participant 3021Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
1087
HPV DNA
1127
Cytology
382

Navigation activity

Barrier documented
431
Contact attempt
737
Navigation intervention
178
Diagnostic booking
618
Diagnostic visit
569

Documented barriers

Contact difficulty
136
Transport difficulty
141
Appointment coordination
154

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.